• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞平衡分数决定乳腺癌的免疫抑制程度和转移能力。

Macrophage balance fraction determines the degree of immunosuppression and metastatic ability of breast cancer.

机构信息

School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.

出版信息

Int Immunopharmacol. 2021 Aug;97:107682. doi: 10.1016/j.intimp.2021.107682. Epub 2021 Apr 23.

DOI:10.1016/j.intimp.2021.107682
PMID:33895480
Abstract

Macrophages are important immune cells in the tumor microenvironment and can be divided into two polarized subtypes, M1 and M2. M1 type macrophages have anti-tumor effects, while M2 type macrophages have pro-tumor effect. Most of the current researches are limited to the effect of M1 or M2 macrophages on tumors, while ignoring the overall balance of macrophages. Our research suggests that the macrophage balance fraction (MBF) can more effectively and comprehensively reflect the balance of tumor associated macrophages. Using bioinformatics analysis and in vitro experiments, we found that MBF is also an effective indicator of the degree of immunosuppression and metastatic ability of breast cancer, and different MBF environment can impact the migration and invasion ability of breast cancer cells. Finally, we also found that the mechanism of MBF changes in breast cancer may be affected by breast cancer-derived exosomes. In summary, MBF was proposed and validated as a novel indicator of macrophage balance state. Using this indicator, we found that the balance of macrophages can affect the degree of immunosuppression and metastatic ability of breast cancer.

摘要

巨噬细胞是肿瘤微环境中的重要免疫细胞,可分为两种极化亚型,M1 和 M2。M1 型巨噬细胞具有抗肿瘤作用,而 M2 型巨噬细胞则具有促肿瘤作用。目前的大多数研究都局限于 M1 或 M2 巨噬细胞对肿瘤的影响,而忽略了巨噬细胞的整体平衡。我们的研究表明,巨噬细胞平衡分数(MBF)可以更有效地、更全面地反映肿瘤相关巨噬细胞的平衡状态。通过生物信息学分析和体外实验,我们发现 MBF 也是乳腺癌免疫抑制程度和转移能力的有效指标,不同的 MBF 环境可以影响乳腺癌细胞的迁移和侵袭能力。最后,我们还发现,乳腺癌中 MBF 变化的机制可能受到乳腺癌来源的外泌体的影响。综上所述,MBF 被提出并验证为一种新的巨噬细胞平衡状态指标。使用这个指标,我们发现巨噬细胞的平衡可以影响乳腺癌的免疫抑制程度和转移能力。

相似文献

1
Macrophage balance fraction determines the degree of immunosuppression and metastatic ability of breast cancer.巨噬细胞平衡分数决定乳腺癌的免疫抑制程度和转移能力。
Int Immunopharmacol. 2021 Aug;97:107682. doi: 10.1016/j.intimp.2021.107682. Epub 2021 Apr 23.
2
Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages.肿瘤来源的外泌体中的 miRNA 转移通过诱导巨噬细胞 M1 极化抑制乳腺癌细胞侵袭和迁移。
Life Sci. 2021 Oct 1;282:119800. doi: 10.1016/j.lfs.2021.119800. Epub 2021 Jul 7.
3
Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.源自表没食子儿茶素没食子酸酯处理的乳腺癌细胞的外泌体通过抑制肿瘤相关巨噬细胞浸润和M2极化来抑制肿瘤生长。
BMC Cancer. 2013 Sep 17;13:421. doi: 10.1186/1471-2407-13-421.
4
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.基于转录组特征定义的 M1 巨噬细胞和 M1/M2 比值仅部分类似于乳腺癌的传统临床特征。
Sci Rep. 2020 Oct 6;10(1):16554. doi: 10.1038/s41598-020-73624-w.
5
Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.外泌体介导的 miR-33 转移诱导小鼠巨噬细胞 M1 极化,并在 4T1 乳腺癌细胞系中发挥抗肿瘤作用。
Int Immunopharmacol. 2021 Jan;90:107198. doi: 10.1016/j.intimp.2020.107198. Epub 2020 Nov 25.
6
Low infiltration of tumor-associated macrophages in high c-Myb-expressing breast tumors.高表达 c-Myb 的乳腺癌肿瘤中肿瘤相关巨噬细胞浸润低。
Sci Rep. 2019 Aug 12;9(1):11634. doi: 10.1038/s41598-019-48051-1.
7
Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis.乳腺癌中巨噬细胞和成纤维细胞的瘤内异质性与肿瘤细胞的形态多样性相关,并促进淋巴结转移。
Immunobiology. 2017 Apr;222(4):631-640. doi: 10.1016/j.imbio.2016.11.012. Epub 2016 Nov 27.
8
Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.构建整合 miRNA 和 mRNA 免疫细胞特征,以预测乳腺癌和卵巢癌患者的生存。
Genes Chromosomes Cancer. 2019 Jan;58(1):34-42. doi: 10.1002/gcc.22688. Epub 2018 Nov 18.
9
Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells.巨噬细胞表型亚型对乳腺癌细胞的上皮-间质可塑性起着截然相反的调节作用。
BMC Cancer. 2016 Jul 7;16:419. doi: 10.1186/s12885-016-2411-1.
10
LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.长链非编码 RNA GNAS-AS1 通过调控 miR-433-3p/GATA3 轴促进 M2 型巨噬细胞极化进而促进 ER+乳腺癌细胞的进展。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20200626.

引用本文的文献

1
Extracellular vesicles: biogenesis mechanism and impacts on tumor immune microenvironment.细胞外囊泡:生物发生机制及其对肿瘤免疫微环境的影响
J Biomed Sci. 2025 Sep 4;32(1):85. doi: 10.1186/s12929-025-01182-2.
2
Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion.肿瘤细胞衍生的细胞外囊泡对免疫逃逸的影响。
Adv Sci (Weinh). 2025 Mar;12(12):e2417357. doi: 10.1002/advs.202417357. Epub 2025 Feb 3.
3
Dysregulation of SIGLEC1 in non-small cell lung cancer: prognostic implications and immunomodulatory role-a multicenter cohort study.
SIGLEC1 在非小细胞肺癌中的失调:预后意义和免疫调节作用——一项多中心队列研究。
J Cancer Res Clin Oncol. 2024 Oct 29;150(10):481. doi: 10.1007/s00432-024-06005-9.
4
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy.肿瘤微环境重塑与癌症免疫治疗中的纳米颗粒。
J Hematol Oncol. 2024 Apr 2;17(1):16. doi: 10.1186/s13045-024-01535-8.
5
Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers.外泌体在结直肠癌进展中的调控作用及其作为生物标志物的潜力。
Cancer Biol Med. 2023 Aug 8;20(8):575-98. doi: 10.20892/j.issn.2095-3941.2023.0119.
6
Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy.揭示乳腺癌患者不同免疫图谱的昼夜节律模式亚型分类,以实现更好的免疫治疗。
Cancer Immunol Immunother. 2023 Oct;72(10):3293-3307. doi: 10.1007/s00262-023-03495-3. Epub 2023 Jul 18.
7
Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.乳腺癌的抗肿瘤治疗:关注肿瘤相关巨噬细胞和纳米药物递送系统。
Cancer Med. 2023 May;12(10):11049-11072. doi: 10.1002/cam4.5489. Epub 2023 Feb 16.
8
Lactate from glycolysis regulates inflammatory macrophage polarization in breast cancer.糖酵解产生的乳酸调节乳腺癌中炎症性巨噬细胞的极化。
Cancer Immunol Immunother. 2023 Jun;72(6):1917-1932. doi: 10.1007/s00262-023-03382-x. Epub 2023 Feb 2.
9
Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.肿瘤相关巨噬细胞的 M1/M2 表型通过 EMT 通路参与调节乳腺癌细胞的恶性生物学行为。
Med Oncol. 2022 May 16;39(5):83. doi: 10.1007/s12032-022-01670-7.
10
Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer.术前全身炎症生物标志物是雌激素受体阳性、人表皮生长因子受体2阴性早期乳腺癌疾病复发的独立预测指标。
Front Oncol. 2021 Nov 4;11:773078. doi: 10.3389/fonc.2021.773078. eCollection 2021.